Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 650 of 1631 entries
View as:

Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT01363336 Org: User:
Start: 11/30/09 End: 07/31/13 Due: 07/31/14

GA YAZ ACNE in China Phase III

Phase: N/A Priority: Normal
NCT ID: NCT00818519 Org: User:
Start: 12/31/08 End: 05/31/10 Due: 05/31/11

Clinical Study on the Effect of Elevit Pregnancy 2nd & 3rd Trimester (Multi-micronutrients & DHA Supplement) on the Nutritional Status of Pregnant Women During Second and Third Trimester

Phase: N/A Priority: Normal
NCT ID: NCT04438928 Org: User:
Start: 09/27/16 End: 12/05/19 Due: 12/05/20

First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT03188965 Org: User:
Start: 07/06/17 End: 09/13/23 Due: 09/13/24

A Digital Non-interventional Atrial Fibrillation (AF) Screening Study With Commercial Pulse Detection Systems

Phase: N/A Priority: Normal
NCT ID: NCT02875106 Org: User:
Start: 11/08/17 End: 05/08/19 Due: 05/08/20

Xirtam H Combination In the Treatment of Hypertension Evaluation Study.

Phase: N/A Priority: Normal
NCT ID: NCT01219556 Org: User:
Start: 11/30/10 End: 02/28/13 Due: 02/28/14

Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01227603 Org: User:
Start: 11/30/10 End: 07/31/11 Due: 07/31/12

The Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women

Phase: N/A Priority: Normal
NCT ID: NCT01861886 Org: User:
Start: 01/31/13 End: 09/30/14 Due: 09/30/15

Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.

Phase: N/A Priority: Normal
NCT ID: NCT02581995 Org: User:
Start: 11/19/15 End: 08/09/17 Due: 08/09/18

Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel 1.5 mg

Phase: N/A Priority: Normal
NCT ID: NCT01073904 Org: User:
Start: 09/30/09 End: 09/30/09 Due: 09/30/10

Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Phase: N/A Priority: Normal
NCT ID: NCT02066402 Org: User:
Start: 03/04/14 End: 04/18/16 Due: 04/18/17

Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT00681551 Org: User:
Start: 02/28/03 End: 03/31/04 Due: 03/31/05

Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections

Phase: N/A Priority: Normal
NCT ID: NCT01967225 Org: User:
Start: 11/23/13 End: 10/28/16 Due: 10/28/17

Bioequivalence Study of BAY77-1931 Granule

Phase: N/A Priority: Normal
NCT ID: NCT01053676 Org: User:
Start: 01/31/10 End: 04/30/10 Due: 04/30/11

Nexavar Dosing in Renal Cancer Patients in "Real-life" Setting

Phase: N/A Priority: Normal
NCT ID: NCT01557127 Org: User:
Start: 11/01/11 End: 03/31/16 Due: 03/31/17

Stivarga Real Life Evidence in Hungary

Phase: N/A Priority: Normal
NCT ID: NCT02656524 Org: User:
Start: 07/01/16 End: 02/15/17 Due: 02/15/18

Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01833793 Org: User:
Start: 02/28/13 End: 05/31/15 Due: 05/31/16

Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of Spain

Phase: N/A Priority: Normal
NCT ID: NCT02262676 Org: User:
Start: 10/31/14 End: 05/31/15 Due: 05/31/16

Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT03290794 Org: User:
Start: 02/14/19 End: 05/26/23 Due: 05/26/24

Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH )

Phase: N/A Priority: Normal
NCT ID: NCT02117791 Org: User:
Start: 07/16/14 End: 09/20/23 Due: 09/20/24

Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01959269 Org: User:
Start: 10/31/13 End: 07/07/17 Due: 07/07/18

Essure Transvaginal Ultrasound (TVU) Study

Phase: N/A Priority: Normal
NCT ID: NCT01327105 Org: User:
Start: 05/17/11 End: 07/04/23 Due: 07/04/24

BAY1830839: First in Man, Single Dose Escalation, Safety & Tolerability and Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT03540615 Org: User:
Start: 06/28/18 End: 08/01/19 Due: 08/01/20

Colorado Adult Joint Assessment Scale (CAJAS) Validation

Phase: N/A Priority: Normal
NCT ID: NCT02284789 Org: User:
Start: 02/28/15 End: 10/31/15 Due: 10/31/16

Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)

Phase: N/A Priority: Normal
NCT ID: NCT02894385 Org: User:
Start: 09/13/16 End: 12/15/17 Due: 12/15/18